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Inhibition of angiotensin-converting enzyme modulates structural and
functional adaptation to loop diuretic-induced diuresis. The roles of
elevated cell sodium concentrations and the angiotensin-aldosterone
system (AAS) in the structural and functional adaptation of the distal
tubule and collecting duct system to a chronic increase of sodium delivery
were examined using electron microprobe and quantitative morphologic!
stereologic analyses. Studies were performed on rats given the loop
diuretic torasemide acutely (20 mm) or chronically (12 days), either alone
or in combination with the angiotensin-converting enzyme (ACE) inhib-
itor, enalapril. In the sodium-absorbing cells of the distal tubule and
cortical collecting duct—that is, in distal convoluted tubule (DCT), con-
necting tubule (CNT) and principal cells—an acute increase in sodium
delivery caused a significant rise in intracellular sodium concentration and
rubidium uptake, the latter an index of in viva Na,K(Rb)-ATPase activity.
The elevated cell sodium concentrations returned to, or close to, control
values during chronic torasemide treatment. Intracellular rubidium con-
centrations, measured after a 30-second rubidium exposure, were not
different from controls in DCT and CNT cells but were still higher in
principal cells. Since, however, the distribution space for rubidium was
significantly increased in chronic torasemide animals, rubidium uptake,
and hence Na,K-ATPase activity, must have increased in proportion to cell
volume in DCT and CNT cells, but more than proportionately in principal
cells. When ACE was inhibited during chronic torasemide, the epithelial
volume of DCT and cortical collecting duct (CCD) was increased mainly
by lengthening and not, as was the case in rats given torasemide alone, by
thickening of the tubule wall. Adaptation of the proximal tubule exclu-
sively by lengthening was not affected by inhibition of the ACE. These data
indicate that changes in cell ion composition may participate in initiating
cell processes leading to adaptation of distal nephron segments to
chronically increased salt delivery. Inhibition of the ACE reverses the
torasemide-induced increase in apparent Na pump density in principal
cells and seems to shift the relationship between hypertrophy and hyper-
plasia noted in DCT and CCD after chronic torasemide in favor of
hyerplasia.
An acute increase in sodium delivery to the distal tubule' and
cortical collecting duct (CCD) is associated with a proportionate
rise in sodium absorption [1—3]. If the increased delivery of
'The term "distal tubule" is used for the nephron segment between the
macula densa and the first confluence with another tubule. This definition
of the distal tubule is used in the micropuncture literature and comprises
the distal convoluted tubule, the connecting tubule and the initial collect-
ing duct.
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sodium to these nephron segments persists, not only functional
but also structural alterations are initiated, which result in a
significant increase in the sodium transport capacity of distal
tubule cells [4—9]. The cellular mechanisms underlying these
adaptive processes are not yet well understood. It has been
suggested that an increment in intracellular sodium concentration
plays a crucial role in the structural and functional adaptation of
the distal tubule and CCD to increased sodium chloride delivery
[10]. Indeed, previous investigations have demonstrated that an
acute rise in sodium load causes intracellular sodium concentra-
tion to rise in the sodium-absorbing cells of these nephron
segments, that is, the distal convoluted tubule (DCT) cell, the
connecting tubule (CNT) cell and the principal cell of the CCD
[11, 12]. Elevated sodium concentrations in these cells were
associated with increased Na,K-ATPase activity as assessed by the
determination of initial rubidium uptake rates in individual tubule
cells [12, 13].
The present investigations were performed to clarify whether
the rise in cell sodium concentration induced by an acute increase
in distal sodium delivery is reversed when the sodium load
remains elevated for a prolonged period. Intracellular electrolyte
concentrations were thus determined in individual tubule cells of
the cortex in control animals and in rats subjected either acutely
or chronically to increased distal sodium delivery. In addition, we
assessed the initial cellular uptake rate of rubidium (a valid
estimate of the in vivo Na,K(Rb)-ATPase activity [13, 14]), to gain
information on the effect of acute and chronic elevation of
transcellular sodium transport on basolateral Na,K-ATPase activ-
ity. Alterations of the distribution space of rubidium induced by
various chronic experimental maneuvers [4, 7, 15] were taken into
account by measuring the absolute volumes of cortical tubule cells
using quantitative morphologic analysis. Finally, to further eluci-
date the role of the angiotensin-aldosterone system (AAS) in the
adaptive processes caused by chronic elevation of sodium delivery
to tubule sites beyond the macula densa, studies were also carried
out in rats in which the angiotensin-converting enzyme (ACE) was
inhibited during the chronic increase in distal sodium load.
Methods
Pretreatment of animals and balance studies
Male Wistar rats (Charles River, Sulzfeld, Germany) were
given a standard rat diet (Alma, Kempten, Germany) and tap
water ad libitum until the day of study. Twelve days prior to
clearance experiments an osmotic minipump (Alzet model 2ML2;
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AIza, Palo Alto, CA, USA) was implanted subcutaneously under
ether anesthesia. The minipumps contained either polyethylene
glycol dissolved in water (20% wt/wt; PEG 400; Merck-Schu-
chardt, Munich, Germany) or torasemide dissolved in PEG/water
(dose: 1.5 mg/hr/kg body wt subcutaneously; the concentration of
torasemide in PEG/water depended on the body wt). The to-
rasemide-treated animals were given a drinking solution contain-
ing 8 g NaCl and I g KCI per liter. Another group of animals
received enalapril in the drinking water (75 mg/liter). Enalapril
treatment was begun two days prior to implantation of an osmotic
minipump loaded with torasemide. During torasemide adminis-
tration enalapril was added to the NaCl/KCI-containing drinking
solution (11 mg/liter). The animals were placed for 24 hours in
individual metabolic cages the day before and the day after pump
implantation and later on days 3, 5, 7, 9 and 12 to monitor
consumption of food and drinking fluid, production of urine and
sodium and potassium excretion. In the torasemide/enalapril-
treated animals, excretion of fluid and electrolytes was also
measured during the first day of enalapril administration.
Clearance studies
After 12 days of treatment, the animals were anesthetized by
intraperitoneal injection of mactin (Byk-Gulden, Konstanz, Ger-
many). Control rats and rats receiving torasemide acutely (see
below) were given 120 mg mactin per kg body wt, those animals
treated chronically with torasemide were given only 80 mg/kg
body wt because chronic administration of loop-diuretics is re-
ported to enhance the susceptibility to anesthetics [4]. The
animals were placed on a thermoregulated operating table which
maintained the body temperature at a preset value (37°C). The
trachea was cannulated and polyethylene catheters were inserted
into the right jugular vein for administering polyfructosan (Inut-
est, Laevosan, Linz, Austria) and into the left femoral artery for
continuous monitoring of blood pressure and withdrawal of
arterial blood samples. The left kidney was exposed via a flank
incision, laid in a plexiglas cup and superfused with warm paraffin
oil (38°C). A catheter was inserted into the ureter near the renal
hilus to allow the timed collection of urine and, hence, determi-
nation of flow rate, inulin, electrolytes and osmolality. Blood
samples were obtained at the endpoints and at the midpoint of the
collection periods for determination of plasma polyfructosan and
electrolyte concentrations, respectively.
Four groups of animals were studied.
Group 1: Controls (N = 6). Animals given PEG for 12 days via
the osmotic minipump received polyfructosan in isotonic saline
(30 g/liter; infusion rate, 10 mI/hr/kg body wt).
Group 2: Acute torasemide (N = 6). Initially, polyfructosan in
isotonic saline was administered as in control animals. During the
last 20 minutes of the experiment a solution containing NaC1 (130
mM), KCI (25 mM) and torasemide was given at a rate of 50
mi/hr/kg body wt in addition to the polyfructosan-containing
saline. The dose of torasemide was 3 mg/hr/kg body wt.
Group 3: Chronic torasemide (N = 6). These animals, with the
torasemide-containing minipump still in place, received polyfruc-
tosan (5 glliter) in a solution containing NaCl (130 mM), KCI (25
mM) at a rate of 100 mi/hr/kg body wt.
Group 4: Chronic torasemide/enalapril (N = 7). These rats,
which received torasemide and enalapril, were treated identically
to group 3 animals.
At the end of the experiment a solution containing 150 mtvi
RbCI was infused into the femoral vein (0.50 mmol/kg body wt)
for 30 seconds [13]. The experiment was terminated by severing
the left renal hilus and shock-freezing the kidney in an isopen-
tane-propane mixture (1:3 vol/vol; —196°C) ['31.
Preparation of freeze-dried clyosections and electron microprobe
analysis
Under liquid nitrogen a small piece of the outermost cortex was
broken from the shock-frozen kidney and fixed in a clamp-type
specimen holder mounted in a precooled (—80°C) ultracryomic-
rotome (Ultrotome V, LKB, Bromma, Sweden). The advance of
the cryotorne was set to deliver 1-pm-thick cryosections. The
cryosections were freeze-dried overnight at —80°C and 10'
mbar, warmed to about 40°C, and then rapidly transferred into a
scanning transmission electron microscope (DSM 950; Zeiss,
Oberkochen, Germany).
Electron microprobe analysis of the freeze-dried cryosections
was carried out using an energy-dispersive X-ray detector system
(Link Systems, High Wycombe, UK) attached to the scanning
electron microscope. The acceleration voltage was 20 kV and the
probe current 0.3 nA. Small areas (1 to 2 sm2) were scanned for
100 seconds and the emitted X-rays analyzed in the energy range
between 0.2 and 20 keV. The cellular measurements were re-
stricted to the nuclei, since X-ray spectra obtained in the nuclei
reflect true intracellular electrolyte concentrations and are not
"contaminated" by contributions originating from extracellular
compartments (that is, basolateral infoldings, apical vesicles).
These nuclear values have been shown to be representative for the
cytosol [161. The different cell types of the distal tubule were
differentiated by criteria detailed previously [17]. Element con-
centrations in mmol/kg wet wt were obtained by a quantification
procedure described in detail elsewhere [181.
Analysis of electrolytes, osmolality and inulin in fluid samples
Sodium and potassium concentrations in plasma, urine and
albumin standard solutions were measured by flame photometry
(IL, Lexington, MA, USA), chloride concentrations electrometri-
cally (Chloridometer 6610; Eppendorf, Hamburg, Germany) and
osmolality by vapor pressure osmometry (5500; Wescor, Logan,
UT, USA). Inulin concentrations in plasma and urine were
measured by the anthrone method [191. Clearance data for
sodium, potassium, and chloride were calculated using standard
formulae.
Stereologic analysis
Kidneys were fixed by retrograde vascular perfusion via the
abdominal aorta and prepared for light microscopy as described in
detail previously [20]. Semi-thin sections of plastic-embedded
specimens of cortical tissue were used to determine volume (V)
and length (Lv) densities of cortical nephron segments by point
counting [21]. To obtain absolute volumes and lengths of proximal
and distal convoluted tubule epithelium, as well as of CCD
epithelium, the relative volume and length estimates (V, L) were
related to the absolute volume of the renal cortex. The latter was
determined as follows. Total kidney volumes were measured by
volume displacement following perfusion fixation. The kidneys
were then sectioned into five equidistant slices perpendicular to
the organ's long axis and embedded in paraplast. One 5-sm,
hematoxylin/eosin-stained section obtained from each of the five
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tissue blocks was used to determine the zonal volumes (cortex,
outer stripe of outer medulla, inner stripe of outer medulla and
inner medulla) by point counting. This procedure allowed the
determination of V of the renal cortex and thence the calculation
of absolute cortex volume. Assessment of the primary morpho-
metric parameters (point counts) was performed in a double-blind
fashion as described in detail elsewhere [201. Acquisition of data
and the subsequent calculations including statistical test proce-
dures were performed using commercially available software
packages (Sigma Scan, Jandel Scientific, Erkrath, Germany; Stat-
graphics, STC, Rockville, MD, USA).
Presentation of data and statistical analysis
The data are presented as means SEM. The mean concentra-
tion of a specific element obtained by electron microprobe
analysis in a specific tubule cell type of one kidney was taken as
one data point for further statistical evaluation. Differences
between the means were tested for statistical significance using
one-way analysis of variance (ANOVA) in combination with the
Student-Newman-Keuls procedure for multiple comparisons
(SPSS/PC software; SPSS Inc., Chicago, IL, USA). For the
quantitative morphologic data, nonparametric, two-tailed, rank
test procedures (Man and Whitney) were used to analyze statis-
tically significant differences between the groups of treatment.
The criterion for statistical significance was P < 0.05.
Results
Fluid and electrolyte excretion in conscious animals
The effects of chronic torasemide and torasemide/enalapril
treatments on fluid and electrolyte excretion in conscious rats are
shown in Figure 1. Urine flow rate (Fig. 1A) and the excretion of
sodium (Fig. 1B) and potassium (Fig. IC) increased 15-, 12- and
2-fold, respectively, by the third day of torasemide treatment.
These high excretion rates were maintained over the following
nine days. When torasemide was administered in combination
with enalapril even higher excretion rates of fluid and electrolytes
were achieved. Interestingly, enalapril alone, elicited slight, but
significant, increments in urine flow rate and in sodium and
potassium excretion (Fig. 1; day 0, which is prior to torasemide
coadministration). This was expected, because it is known that
interference with the generation of angiotensin inhibits proximal
absorption of salt and water [221.
Blood values and parameters of renal function in anesthetized
animals
Table 1 summarizes serum sodium, chloride and potassium
concentrations, serum osmolality, hematocrit values and body
weights obtained during anesthesia in control rats, in rats receiv-
ing torasemide acutely and in rats with chronic torasemide or
torasemide/enalapril treatment. These data were obtained on
plasma samples collected during the 30 (hydropenic controls) or 8
(diuretic, torasemide-treated rats) minutes preceding the rubid-
ium infusion. Serum sodium and potassium concentrations, he-
matocrit values and body weights were not significantly different
between the four groups. Serum chloride concentration was
slightly, but significantly, higher in those animals receiving to-
rasemide acutely. Prior to torasemide administration plasma
chloride concentrations did not differ significantly from those of
control animals. Serum osmolality was significantly lower in
Time, days
Fig. 1. Effect of chronic torasemide administration either alone (A, N =13)
or in combination with the ACE inhibitor enalapril N = 15) on the daily
excretion of urine (A), sodium (B) and potassium (C). Abbreviations are: V,
urine flow, UNaV, daily sodium excretion, UKV, daily potassium excretion.
Open squares () are control values (N = 10); values are mean SEM.
*Significantly different from corresponding control values; #significantly
different from corresponding value obtained in animals treated with
torasemidc alone.
animals with chronic torasemide/enalapril treatment than in con-
trols or in rats receiving torasemide acutely.
Renal functional data during anesthesia in the various groups of
rats are shown in Table 2. These results were obtained also during
the collection period preceding the rubidium infusion. Acute
administration of torasemide caused a significant reduction of
urine osmolality and a sharp rise in urine flow rate and in urinary
sodium, chloride and potassium excretion. Glomerular filtration
rate, however, was not altered. The effects on urine flow rate,
urine osmolality and on the excretion of sodium, chloride and
potassium were even more pronounced with chronic administra-
tion of the loop diuretic either alone or in combination with the
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of intracellular rubidium concentrations in DCT and CNT cells,
but not in principal cells. When, however, torasemide exerted its
action while the ACE was blocked, cell rubidium concentrations
in DCT, CNT and principal cells were not significantly different
from controls (Fig. 2). Following short-term administration of
torasemide, intracellular chloride concentrations were signifi-
cantly increased in DCT and CNT but not in principal cells. These
alterations in cell chloride concentrations were no longer detect-
able in animals receiving the loop diuretic chronically.
Electron microprobe analyses were also performed on interca-
lated cells. These were classified according to their intracellular
4.5 0.1 4.2 0.2 chloride concentrations into high (type I) and low (type II)
chloride cells [23]. In neither cell type were sodium, chloride or
281 13h rubidium concentrations affected significantly by any of the exper-
imental maneuvers, except for a slight, but significant, increase in
46.1 1.5 46.8 0.9 cell sodium concentration in type I intercalated cells of animals
270 6 282 7 treated chronically with torasemide alone (14.0 0.3 vs. 11.9
0.8 mmol/kg wet wt in controls; Fig. 2). Neither cell phosphorus
concentrations nor cell dry weights were altered significantly in
the three experimental groups in any of the cell types examined
(data not shown).
Stereologic data
ACE inhibitor. In both groups receiving torasemide chronically,
glomerular filtration rate was significantly increased (Table 2).
Intracellular element concentrations and cell rubidium uptake
Intracellular sodium and chloride concentrations determined in
the different tubule cell types of the renal cortex of PEG-treated
controls, of rats given torasemide either acutely or chronically,
and of animals receiving torasemide plus enalapril are shown in
Figure 2. Intracellular rubidium concentrations obtained after a
30-second rubidium infusion arc also presented. Neither treat-
ment had any measurable effect on intracellular sodium, rubidium
or chloride concentration of proximal convoluted tubule (PCT)
cells. In the sodium-absorbing cells of the distal tubule and CCD
(that is, in DCT, CNT and principal cells), the acute increase of
distal sodium delivery caused cell sodium concentration and
rubidium uptake to rise. Following short-term administration of
torasemide, sodium concentration in DCT, CNT and principal
cells increased from 11.1 0.8, 10.5 0.6 and 11.7 1.2 mmol/kg
wet wt under control conditions to 15.7 1.0, 17.2 0.6, and
16.1 1.2 mmol/kg wet wt, respectively. When high rates of
sodium delivery to the distal tubule and CCD were maintained for
12 days, cell sodium concentrations remained slightly but signifi-
cantly elevated in DCT cells (13.6 0.3 mniol!kg wet wt) but no
longer differed from control values in CNT (12.7 1.0) and
principal (12.9 0.6 mmol/kg wet wt) cells. Cell sodium concen-
trations indistinguishable from controls were obtained in DCT,
CNT and principal cells of animals chronically receiving to-
rasemide in combination with enalapril. The increased cell sodium
concentrations noted during acutely increased distal sodium de-
livery in DCT, CNT and principal cells were associated with
enhanced cell rubidium uptake. Cell rubidium concentrations
after a 30-second rubidium infusion in DCT, CNT and principal
cells rose from 46.4 3.1, 38.3 1.7 and 29.0 2.3 mmol/kg wet
wt under control conditions to 57.6 2.9, 47.7 3.8, and 39.2
2.2 mmol/kg wet wt, respectively. Prolonged exposure to elevated
lumen sodium concentrations was accompanied by normalization
The kidney volumes obtained after perfusion fixation were
1385 26 jsl (N = 5) in PEG-treated controls, 1960 90 pi (N =
5; P < 0.05 vs. controls) in animals chronically receiving to-
rasemide, and 2068 63 pi (N = 6; P < 0.05 vs. controls) in those
animals given torasemide in combination with enalapril. This
increase in kidney size was mainly due to corresponding alter-
ations in the volume of the cortex (Fig. 3). Outer and inner stripes
of outer medulla and inner medulla, however, were also signifi-
cantly enlarged in the experimental groups (Fig. 3). Total glomer-
ular volume significantly increased from 48.5 8.0 j.rI in controls
to 67.5 5.8 and 82.5 4.5 d in torasemide- and torasemide/
enalapril-treated rats, respectively.
While long-term administration of torasemide did not affect the
absolute volume of the proximal tubule epithelium (277.3 19.0
vs. 245.5 12.4 p.1 in controls), the treatment with torasemide in
combination with enalapril caused a significant increase to
316.7 18.3 p.! (Fig. 4A). The volumes of both the DCT and the
collecting duct epithelium were significantly higher in both exper-
imental groups. In torasemide-treated rats the DCT epithelium
increased from a control of 50.0 4.3 to 95.6 4.0 p.!, and the
collecting duct epithelium from 11.0 1.6 to 20.8 1.2 .tl.
Similar alterations were observed in the torasemide/enalapril
group (DCT, 93.9 6.9; collecting duct, 26.8 2.4 p.l).
The increase in proximal tubule volume of torasemide/enala-
pril-treated rats (30% vs. controls) can be fully accounted for by
the increment in absolute tubule length (43% vs. controls; Fig.
4B). The greater volumes of the DCT and collecting duct epithe-
hum in the torasemide/enalapril group (88% and 144% vs.
controls) are also mostly due to increased length of the respective
tubule segments, since the length of the DCT was 60% and that of
the collecting duct 118% greater than in the control group (Fig.
4). In torasemide-treated rats, however, the increased volumes of
the DCT and collecting duct epithelium must be attributed to
both lengthening of the tubule segments and thickening of the
epithelial wall, since the increment in epithelial volume (91% and
89% vs. control for the DCT and collecting duct) is much greater
Table 1. Serum electrolytes, hematocrit and body weight in control
rats, in rats treated acutely with torasemide and in rats chronically given
torasemide or torasemide in combination with enalapril
(Tora/Enal)
Torasemide Torasemide
Controls acute chronic
Tora/Enal
chronic
140.7 1.7 143.7 1.9 142.0 1.5 142.4 1.7Serum sodium
concentration
mmol/liter
Serum chloride
concentration
mmol/liter
Serum potassium
concentration
mmol/liter
Serum osmolality
mOsm/kg
Hematocrit %
Body weight g
No. animals
103.6 0.8 108.3 0.T 106.3 1.7 102.4 1.7'
4.0 0.2 4.1 0.1
288 0.4 287 1.7 286 1.5
46.7 1.0
287 10
6
43.7 1.0
285 10
6
Data are means SEM.
U Significantly different from corresponding control valuehSignificantly different from corresponding value of animals given
torasemide acutely
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Fig. 2. Sodium (A), mbidium (B) and chloride (C) concentrations in renal
tubule cells of control rats (LII, N = 6), in animals treated acutely with
torasemide (, N = 6) and in rats given chronically torasemide (, N = 7)
or torasemide in combination with enalapril (L N = 7). Abbreviations are:
PCT, proximal convoluted tubule; DCT, distal convoluted tubule; CNT,
connecting tubule. Values are mean SEM. *significantly different from
the corresponding control value; #significantly different from correspond-
ing value obtained in animals with acute torasemide treatment;
• significantly different from corresponding value obtained in animals with
chronic torasemidc treatment.
than the corresponding increase in absolute tubule length (34%
and 39%; Fig. 4).
The measured increase in segmental length following treatment
with torasemide alone was 44.4 m for the DCT and 14.9 m for the
collecting duct. Combined treatment with torasemide/enalapril
resulted in length increments of 76.5 and 45.0 m, respectively. If
* *
Cortex OMOS OMIS IM
Fig. 3. Absolute volumes of the various kidney zones in control rats (El, N
5), in rats chronically given torasemide (, N = 5) or torasemide in
combination with enalapril (1:: N = 6). Abbreviations are: OMOS, outer
medulla outer stripe; OMIS, outer medulla inner stripe; TM, inner medulla
(including papilla). Values are mean SEM. *significantly different from
the corresponding control value.
one assumes that segmental length were to increase without a
change in epithelial cross-sectional area (epithelial wall thick-
ness), the volume increment would be + 17.2 j.rl (torasemide) and
+29.7 d (torasemidc/enalapril) for the DCT and +4.3 .d (to-
rasemide) and +13.0 ,rLl (torasemide/enalapril) for the collecting
duct. The increments actually measured were, however, larger
(+45.6 p.l after torasemide and +43.9 pi after torasemide/
enalapril for the DCT and +9.8 pJ after torasemide and +16.8 d
after torasemide/enalapril for the collecting duct). Therefore
differences remain (+28.4 .rl for the DCT and + 5.5 p.l for the
collecting duct after torasemide; +14.2 i.rl for the DCT and +2.8
.d for the collecting duct after torasemide/enalapril) that cannot
be explained by length increase alone, but must include an
increase in the cross sectional area of the two nephron segment
profiles, which thus corresponded to an increase in epithelial wall
thickness. The fractional volume increments based on a gain in
either segmental length or segmental epithelial cross-sectional
area (wall thickness) are given in Figure 5.
Discussion
Mieropuncture experiments in situ have demonstrated that both
acute and chronic administration of ioop diuretics enhance the
delivery of sodium and chloride to the distal tubule and initial
collecting duct [7, 24]. When sodium delivery to these nephron
segments is increased in acute experiments, sodium absorption
Table 2. Parameters of renal function in control rats, in rats treated acutely with torasemide and in rats given chronically torasemide or
torasemide in combination with enalapril (Tora/Enal)
Torasemide Torasemide Tora/Enal
Controls acute chronic chronic
Urine flow rate pJ/min/100 g body wt 2.4 1.1 30.1 9.9" 122.3 3.6"" 134.5 3.6""
Glomerular filtration rate mI/mini] 00 g body wt
Urine osmolality mOsm/kg
Sodium excretion pmollmin/100 g body Wi
Fractional sodium excretion %
0.53 0.02
2463 396
0.28 0.17
0.4 0.3
0.47 0.02
496 54"
4.32 1.24"
6.1 1.4"
0.68 004th
314 6""
15.79 0.59""
16.7 0.9"
0.73 0.02""
298 10""
16.60 0.62""
16.2 0.6"
Chloride excretion pmolIminIlOO g body WI 0.45 0.15 5.03 1.35" 18.39 0.68"" 19.15 065""
Fractional chloride excretion % 0.9 0.3 9.4 2.0" 26.1 1.7"" 25.9 0.7""
Potassium excretion unolimin/100g body wt
Fractional potassium excretion %
0.38 0.08
20.0 5.0
1.03 0.11"
52.7 3.7"
2.71 0.08"
91.8 6.0"
2.95 0.10""
99.4 58ah
No. animals 6 6 7 7
Data are mean SEM.
a Significantly different from corresponding value of control animals
Significantly different from corresponding value of animals given torasemide acutely
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Fig. 4. Absolute volumes (left) and lengths (right) of proximal tubule (A),
distal convoluted tubule (B), and collecting duct (C) of control rats (LI, N =
5), in rats given chronically torasemide (, N = 5) and in animals treated
with torasemide in combination with enalapril (Li, N = 6). The "collecting
duct" also included the connecting tubule. Data are mean SEM.
*Significantly different from corresponding control value; #significantly
different from corresponding value obtained in animals with chronic
torasemide treatment.
rises significantly [1—3]. The present investigation shows that
intracellular sodium concentration and rubidium uptake in DCT,
CNT and principal cells rise during an acute increase in salt
delivery. These observations confirm results from previous exper-
iments suggesting that the initial event in transport stimulation is
an increment in sodium influx across the apical cell membrane
causing cell sodium concentration to rise and, secondarily, activa-
tion of Na,K(Rb)-ATPase [11—i 3].
On the other hand, a chronically elevated distal salt load
induces adaptive processes leading to increases in epithelial
volume and basolateral membrane area in the distal tubule and
CCD as well as an augmented transport capacity [4—9]. Our study
is the first to demonstrate that the increase in cell sodium
concentration induced by an acute rise in sodium delivery is
mitigated, or even reversed, if the elevation of lumen sodium
concentration persists for several days. In this situation enhanced
transcellular transport of sodium is achieved at normal or near-
normal cell sodium concentrations. This implies that factors other
than elevated cell sodium concentrations, such as increased
numbers of transport proteins in both apical and basolateral cell
membranes, must be responsible for the high rates of transcellular
sodium transport. The triggers, however, that effect the structural
.gi and functional adaptation in the sodium-absorbing cells in this
nephron region to increased salt delivery are largely unknown.
Changes in cell sodium concentrations have been suggested to
affect cell growth and differentiation and thus contribute to these
adaptive processes [10, 25, 26]. For instance, the activity of
transport proteins that depend on steep transmembrane sodium
concentration gradients, such as Na/H- or Na/Ca-exchangers, is
modulated by changes in cell sodium concentration. Elevated cell
sodium concentrations may thus lead to changes in calcium and
hydrogen ion activities. Since altered cell calcium and proton
concentrations are known to modulate cell growth [27—29], it is
conceivable that these factors also participate in the adaptation of
sodium-absorbing cells of the distal tubule to an increased work
load. In addition, specific metabolites (such as ADPorAMP) may
also influence gene expression [30, 31]. In epithelial cells ATP
consumption is highly dependent on Na,K-ATPase activity [32],
which is effectively modulated by the intracellular sodium concen-
tration. Consequently, changes in cell sodium also affect the
concentration of ATP and its metabolites and thus contribute to
the adaptive processes. The present results agree with the notion
that increased cell sodium concentrations participate in the
initiation of processes that culminate in the full adaptation of
distal tubule cells to chronically increased salt delivery. The
observation, however, that after prolonged exposure of distal
tubule cells to elevated lumen sodium chloride concentrations,
intracellular sodium concentrations return to, or close to, control
values suggests that increased cell sodium concentrations contrib-
ute less to the maintenance of the adapted state.
The finding that intracellular rubidium concentrations deter-
mined in DCT and CNT cells of rat with chronically increased
distal sodium delivery did not differ from the corresponding
values of control animals does not necessarily imply that Na,K-
ATPase activity was unchanged within these cells. Since, as
discussed in greater detail below, the volume of these tubule
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segments was enlarged after chronic torasemide, the amount of
rubidium taken up into an increased distribution space must have
increased with increasing cell volume. In case of DCT cells, a
portion of this increased rubidium uptake may be due to stimu-
lation of the Na,K-ATPase by the slightly elevated cell sodium
concentrations (Fig. 2). The remainder of this increase in rubid-
ium uptake in DCT cells and the major component of the
enhanced rubidium uptake in CNT cells, however, is most likely
attributable to an increase in the Na,K-ATPase transport sites,
concomitant with the increase in cell volume during chronic
torasemide treatment [8].
The fact that rubidium uptake in principal cells remained
elevated after 12 days of torasemide suggests that the number of
Na,K-ATPase molecules in these cells had risen disproportion-
ately to cell volume. Since inhibition of ACE impeded this
increment in rubidium uptake, it may be concluded that angio-
tensin and/or aldosterone play a decisive role in exaggerated
stimulation of principal cell Na,K-ATPase. Chronic administra-
tion of loop-diuretics has been shown to be associated with
stimulation of the renin-angiotensin-aldosterone system [9, 331
The present experiments do not allow discrimination between
aldosterone or angiotensin II (or both) as the responsible fac-
tor(s) for the disproportionate stimulation of principal cell Na-
,K(Rb)-ATPase noted after chronic torasemide administration.
Evidence indicates that the CCD is not only a main target site for
aldosterone but may also be subject to regulation by angiotensin
11134—361.
It should be noted that inhibition of ACE interferes not only
with the AAS, but may also influence other hormonal systems.
Specifically, ACE inhibition increases bradykiniri levels, since
ACE contributes substantially to the degradation of this kinin,
and enhances prostaglandin E production [371. There is evidence,
however, that loop diuretics such as furosemide alone stimulate
these hormonal systems [381. If the Na,K-pump density in princi-
pal cells were to be increased by these hormonal systems as a
result of chronic torasemide alone, it is difficult to imagine that a
further rise in these hormones, as the result of the combined
torasemide/enalapril treatment, should now reverse the increase
in apparent Na pump density.
The higher cell chloride concentrations noted in DCT and CNT
cells after acute elevation of distal sodium chloride delivery may
be caused either by coupled entry of sodium and chloride from the
lumen or by depolarization of the cell membrane potential due to
electrogenic influx of sodium. Another factor that could contrib-
ute to the increment in cell chloride concentration is the increase
in plasma chloride concentration in these animals (Table 1).
Results from previous studies support the notion that the inter-
stitial chloride concentration (at the basolateral cell boundary) is
an important determinant of the intracellular chloride concentra-
tion [181.
The chronic increase in work load induced by torasemide or
torasemide/enalapril treatment caused a significant increase in the
epithelial volume of the proximal and distal convoluted tubule
and the CCD. In the case of the proximal tubule, the rise in
epithelial volume can be fully accounted for by lengthening (Fig.
4). For the DCT, however, only some 38% (torasemide) and 68%
(torasemide/enalapril) of the increased epithelial volume is due to
greater tubule length, implying that approximately 62% and 32%,
respectively, must be ascribed to thickening of the epithelial wall
(Figs. 4 and 5). While in torasemide-treated rats some 56% of the
larger epithelial volume of the CCD can be accounted for by
increased cell height, in the torasemide/enalapril group only some
18% of the volume increase is due to thickening of the epithelial
wall (Figs. 4 and 5).
It is evident that the proximal tubule responds to the chronically
elevated glomerular filtration rates in the torasemide and to-
rasemide/enalapril-groups with a corresponding increase in epi-
thelial volume. The observation that this is exclusively due to
lengthening of the proximal tubule is surprising, since in rats with
chronic hyperfiltration induced by unilateral nephrectomy both
increased tubule length and cell height contribute to the larger
cell volumes in those animals [39]. Clearly, preferential lengthen-
ing of the proximal tubule will increase the resorptive area of the
brush border membranes far more effectively than an equivalent
volume increase achieved by thickening of the epithelial wall.
Recent experiments by Loffing, Le Hir and Kaissling provide
evidence for increased DNA synthesis of proximal tubule cells
after 72 hours of continuous furosemide treatment [40]. These
and the present observations suggest that cell proliferation may
play an important role in the adaptive increase of proximal tubule
volume induced by chronic administration of loop diuretics. The
finding that inhibition of the ACE did not alter structural adap-
tation of the proximal tubule suggests that neither angiotensin II
nor aldosterone are decisive components of the regulatory cas-
cade adjusting the structure of proximal tubules to the chronically
increased work load produced by continuous application of loop
diuretics.
In DCT and collecting duct cells, however, chronic torasemide
administration caused an enlargement of the epithelial volume
mainly by increased cell height. This substantiates the above
statement that the distribution space for rubidium is substantially
increased in these segments. An unchanged rubidium concentra-
tion measured after 30 seconds of rubidium infusion thus implies
that the total amount of rubidium taken up by these cells is
increased in proportion to cell volume. The present finding of an
increment in rubidium uptake proportional to cell volume in DCT
and CNT cells may be best explained by a rise in the number of
functional Na,K-ATPase molecules in proportion to the increase
in cell volume. In principal cells of the chronic torasemide group,
however, rubidium concentrations were higher than those of
control animals, suggesting that—compared with cell volume—the
number of Na,K-ATPase molecules rose out of proportion.
When torasemide treatment is combined with inhibition of the
ACE, an increase in wall thickness contributes only little to the
enlargement of the epithelium volume in both DCT and CCD.
This finding supports the view that angiotensin II and/or aldoste-
rone participate in the structural adaptation of these tubule
segments to chronic, loop-diuretic induced increases in distal
sodium delivery. This notion agrees with observations indicating
that both the DCT and CCD are target sites for both angiotensin
II and aldosterone [34—36, 41]. Interestingly, interference with the
AAS does not prevent structural adaptation of these nephron
segments per Se, but rather alters its nature. With the AAS intact,
adaptation is accomplished mainly by wall thickening (presumably
cell hypertrophy); with the AAS impaired, adaptation is achieved
primarily by lengthening of the tubule epithelium (presumably cell
hyperplasia) instead of wall thickening (Fig. 5).
In summary, these results are consistent with the notion that
increased intracellular sodium concentrations contribute to the
initiation, but rather less so to the maintenance of processes
adjusting the transport capacity of sodium-absorbing cells of the
distal tubule and CCD to chronic high salt delivery caused by
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continuous administration of ioop diuretics. The increase in
apparent Na pump density in principal cells after chronic treat-
ment with the loop diuretic torasemide is reversed by concomitant
administration of the ACE inhibitor enalapril. In both DCT and
CCD, inhibition of the ACE appears to alter the characteristcs of
the torasemide-induced structural adaptation (hypertrophy corn-
pared with hyperplasia) in favor of hyperplasia.
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